2010 Press Release

Innovative projects are selected for their potential to accelerate discovery and deliver game-changing results for prostate cancer

SANTA MONICA, CA/May 12, 2010—The Prostate Cancer Foundation (PCF) today announced that it has funded twelve new Creativity Awards to support innovative projects because of their potential to fast-forward discovery and deliver game-changing results for prostate cancer research. These two-year awards are designed to support new ideas that may lead to the development of better diagnostics, new treatments and even cures for prostate cancer. The type of research ideas encouraged by PCF’s Creativity Awards are typically not funded by any existing government or other private sources.

“We continue to lose an American man to prostate cancer every 19 minutes and more than 192,000 new cases will diagnosed this year,” said Howard Soule, PhD, executive vice president and chief scientist for PCF. “New approaches for treating this disease are urgently needed. The talent and creative thinking of these 12 award recipients will feed our discovery pipeline and cultivate new solutions for the prostate cancer.”

A rigorous peer review process vetted the 12 selected projects from a field of more than 157 applications representing 92 institutions in 11 countries. Historically, 70 percent of such PCF awards have gone on to attract additional multi-year funding from PCF and other sources.

“Seven of these new Creativity Awards fund entirely new classes of anti-prostate-cancer medicines that have never before entered clinics,” commented Jonathan W. Simons, MD, president and CEO of PCF. “With these awards, we are replenishing our pipeline of potentially promising new treatments for patients.”

Learn more about PCF's 2010 Creativity Award Winners